Solventum Names Parag Kachalia Global Clinical Evidence Director
New role will focus on clinical strategy supporting the company’s digital dental solutions.
By
News Staff
September 28, 2026
Clinical Scorecard: Solventum Names Parag Kachalia Global Clinical Evidence Director
At a Glance
Category Detail
Condition Clinical topic addressed by the source article: Solventum Names Parag Kachalia Global Clinical Evidence Director
Key Mechanisms Mechanisms or clinical associations described in the source article.
Target Population Patients or participants described in the source article.
Care Setting Specify the type of digital dental solutions.
Key Highlights
Parag Kachalia appointed as global clinical evidence director. 25 years of experience in clinical practice and dental technology. Former head of clinical practice at Overjet. Recognized in Incisal Edge’s 32 Most Influential People in Dentistry. Focus on developing digital workflows for diagnostic accuracy.
Guideline-Based Recommendations
Diagnosis
Include any relevant diagnostic guidelines if applicable.
Management
Include any relevant management guidelines if applicable.
Monitoring & Follow-up
Include any relevant monitoring guidelines if applicable.
Risks
Include any relevant risk guidelines if applicable.
Patient & Prescribing Data
Specify the target patient demographics if available.
Clinical Best Practices
Utilization of artificial intelligence in clinical workflows. Integration of academic research into clinical practice.
Related Resources & Content